EFFECTIVENESS OF RITUXIMAB AS FIRST AND SECOND LINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Mahrnoud, I. [1 ]
Jradi, S. [1 ]
Saidane, O. [1 ]
Rekik, S. [2 ]
Sahli, H. [1 ]
Elleuch, M. [2 ]
Tekaya, R. [1 ]
Abdelmoula, L. [1 ]
机构：
[1] Tunisia Charles Nicolle Hosp, Rhumatol Dept, Tunis, Tunisia
[2] La Rabta Hosp, Rhumatol Dept, Tunis, Tunisia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.6350
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0418
引用
收藏
页码：1033 / 1033
页数：1
相关论文
共 50 条
  • [1] TOCIUZUMAB EFFECTIVENESS AS FIRST LINE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Jarpa, E.
    Jara, C.
    Vergara, C.
    Jurado, M.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S39 - S39
  • [2] TOFACITINIB: FIRST OR SECOND LINE OF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS?
    Valencia, Omaira
    Villarreal, Laura
    Cabrera, Michael
    Santos-Moreno, Pedro
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 119 - 119
  • [3] Effectiveness of Rituximab in rheumatoid arthritis
    Marti-Navarro, Marta
    Frias-Lopez, Carmen
    Gomez-Centeno, Toni
    Campos, Begona
    Humbert, Sarai
    Salvador, Roger
    Altimiras-Ruiz, Joan
    PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 728 - 729
  • [4] Rituximab therapy in Greek patients with rheumatoid arthritis
    Tsiakalos, Aristotelis P.
    Avgoustidis, Nestor K.
    Moutsopoulos, Haralampos M.
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 911 - 916
  • [5] Lessons for rituximab therapy in patients with rheumatoid arthritis
    Garcia-Montoya, Leticia
    Villota-Eraso, Catalina
    Yusof, Md Yuzaiful Md
    Vital, Edward M.
    Emery, Paul
    LANCET RHEUMATOLOGY, 2020, 2 (08): : E497 - E509
  • [6] Rituximab therapy in patients with resistant rheumatoid arthritis
    Masding, A.
    Jois, R. N.
    Somerville, M.
    Gaffney, K.
    Scott, D. G. I.
    RHEUMATOLOGY, 2007, 46 : I27 - I27
  • [7] A comprehensive review of rituximab therapy in rheumatoid arthritis patients
    Tavakolpour, Soheil
    Alesaeidi, Samira
    Darvishi, Mohammad
    GhasemiAdl, Mojtaba
    Darabi-Monadi, Sahar
    Akhlaghdoust, Meisam
    Behjati, Somayeh Elikaei
    Jafarieh, Arash
    CLINICAL RHEUMATOLOGY, 2019, 38 (11) : 2977 - 2994
  • [8] A comprehensive review of rituximab therapy in rheumatoid arthritis patients
    Soheil Tavakolpour
    Samira Alesaeidi
    Mohammad Darvishi
    Mojtaba GhasemiAdl
    Sahar Darabi-Monadi
    Meisam Akhlaghdoust
    Somayeh Elikaei Behjati
    Arash Jafarieh
    Clinical Rheumatology, 2019, 38 : 2977 - 2994
  • [9] THE IMPACT OF RITUXIMAB THERAPY ON THE CHROMOSOMES OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Sokolovic, Sekib
    Kasumagic, Sida
    Mackic-Durovic, Mirela
    Aganovic-Musinovic, Izeta
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2010, 10 (02) : 121 - 124
  • [10] A COST-EFFECTIVENESS ANALYSIS OF ABATACEPT, TOCILIZUMAB, AND TNF-INHIBITOR COMPARED WITH RITUXIMAB AS A SECOND-LINE THERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS
    Huoponen, S.
    Aaltonen, K. J.
    Joensuu, J. T.
    Rutanen, J.
    Relas, H.
    Taimen, K.
    Puolakka, K.
    Sokka, T.
    Nordstrom, D.
    Blom, M.
    VALUE IN HEALTH, 2016, 19 (07) : A538 - A538
12345